Semaglutide is a synthetic peptide that has been the subject of extensive research due to its intriguing role in glucose metabolism. Scientific investigations have primarily focused on its ability to regulate insulin secretion, which has significant implications for the study of glucose homeostasis and diabetes-related conditions in non-human models. In controlled laboratory settings, Semaglutide has demonstrated a capacity to influence the secretion of insulin and glucagon, making it a peptide of interest among researchers delving into the mechanisms of pancreatic function and metabolic regulation.